125 related articles for article (PubMed ID: 30829607)
1. PHENOTYPIC CHARACTERISTICS OF CHORIONIC VILLI DURING GESTATIONAL TROPHOBLASTIC DISEASES.
Chikvaidze N; Kintraia N; Muzashvili T; Gachechiladze M; Burkadze G
Georgian Med News; 2019 Jan; (286):140-145. PubMed ID: 30829607
[TBL] [Abstract][Full Text] [Related]
2. PHENOTYPIC CHARACTERISTICS OF TROPHOBLASTIC HYPERPLASIA AND MICROENVIRONMENT ALTERATIONS IN CHORIONIC VILLI IN SPONTANEOUS ABORTIONS.
Chikvaidze N; Kintraia N; Muzashvili T; Gachechiladze M; Burkadze G
Georgian Med News; 2019 Jun; (291):117-121. PubMed ID: 31418743
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
[TBL] [Abstract][Full Text] [Related]
5. Intact Chorionic Vesicle in Very Early Products of Conception Specimens: Clinicopathologic Features of 26 Cases That May Mimic Complete Hydatidiform Mole.
Kayraklioglu N; Gasper C; Cho SJ; Lage J; Rabban JT
Am J Surg Pathol; 2023 Mar; 47(3):397-408. PubMed ID: 36729386
[TBL] [Abstract][Full Text] [Related]
6. [Pathology of gestational trophoblastic tumors].
Vuong PN; Guillet JL; Houissa-Vuong S; Lhommé C; Proust A; Cristalli B
Gynecol Obstet Fertil; 2000 Dec; 28(12):913-26. PubMed ID: 11192198
[TBL] [Abstract][Full Text] [Related]
7. p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases.
Gaillot-Durand L; Patrier S; Aziza J; Devisme L; Riera AC; Marcorelles P; Pelluard F; Gasser B; Mauduit C; Hajri T; Massardier J; Bolze PA; Golfier F; Devouassoux-Shisheboran M; Allias F
Hum Pathol; 2020 Jul; 101():18-30. PubMed ID: 32387104
[TBL] [Abstract][Full Text] [Related]
8. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
9. P57kip2 immunohistochemical expression and ultrastructural findings of gestational trophoblastic disease and related disorders.
Soma H; Osawa H; Oguro T; Yoshihama I; Fujita K; Mineo S; Kudo M; Tanaka K; Akita M; Urabe S; Kudo Y
Med Mol Morphol; 2007 Jun; 40(2):95-102. PubMed ID: 17572845
[TBL] [Abstract][Full Text] [Related]
10. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
Lösch A; Kainz C
Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
[TBL] [Abstract][Full Text] [Related]
12. Trophoblast proliferation rate does not predict progression to persistent gestational trophoblastic disease in complete hydatidiform mole.
Jeffers MD; Richmond JA; Smith R
Int J Gynecol Pathol; 1996 Jan; 15(1):34-8. PubMed ID: 8852444
[TBL] [Abstract][Full Text] [Related]
13. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta.
Kim KR; Park BH; Hong YO; Kwon HC; Robboy SJ
Am J Surg Pathol; 2009 Feb; 33(2):176-85. PubMed ID: 18936691
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
[TBL] [Abstract][Full Text] [Related]
15. [Persistent gestational trophoblastic disease following ectopic molar pregnancy].
Voloshchuk IN; Barinova IV; Buyanova SN; Petrakova SA; Shchukina NA; Mgeliashvili MV
Arkh Patol; 2021; 83(1):44-48. PubMed ID: 33512127
[TBL] [Abstract][Full Text] [Related]
16. Histopathological and immunohistochemical features of early hydatidiform mole in relation to subsequent development of persistent gestational trophoblastic disease.
Petts G; Fisher RA; Short D; Lindsay I; Seckl MJ; Sebire NJ
J Reprod Med; 2014; 59(5-6):213-20. PubMed ID: 24937960
[TBL] [Abstract][Full Text] [Related]
17. [Morphological investigation in microscopic mole].
Ito K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jul; 44(7):853-8. PubMed ID: 1500807
[TBL] [Abstract][Full Text] [Related]
18. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
[TBL] [Abstract][Full Text] [Related]
19. [Expression of TM4SF9 in human trophoblasts].
Gao TY; Yu YH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1080-2. PubMed ID: 18583270
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases.
Abdou A; Kandil M; El-Wahed MA; Shabaan M; El-Sharkawy M
Fetal Pediatr Pathol; 2013 Dec; 32(6):395-411. PubMed ID: 23438793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
